INDRAPRASTHA MEDICAL CORP Share Price

INDRAPRASTHA MEDICAL CORP Share Price

NSE: INDRAMEDCO
|
Healthcare Services
|
S Cap
₹ 356.35
+₹4.00 (1.14%)
1D
Last updated 03 Sep, 2026, 15:29 IST

INDRAPRASTHA MEDICAL CORP Share Price Today

As of 4 Sep 2026, INDRAPRASTHA MEDICAL CORP share price is ₹356.35. The stock opened at ₹355.60, compared to its previous close of ₹352.35. During today's trading session, INDRAPRASTHA MEDICAL CORP share price moved in the range of ₹352.35 to ₹360.00, with an average price of ₹356.18 for the day. Looking at its last 52-week, the stock has touched a low of ₹342.00 and a high of ₹640.85.


₹352.35
1.14% up today
₹360.00
1D LOW
1D HIGH

INDRAPRASTHA MEDICAL CORP Returns Calculator


Circuit
L
H
₹281.90
₹422.80
52-week
L
H
₹342.00
₹640.85

About INDRAPRASTHA MEDICAL CORP

INDRAPRASTHA MEDICAL CORP Share Price
ISIN
INE681B01017
Sector Market Cap
₹ 3,231.93 Cr

Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.

INDRAPRASTHA MEDICAL CORP Financial Highlights

  • Revenue: INDRAPRASTHA MEDICAL CORP reported revenue of ₹1,511.26 crore in FY26 vs ₹1,379.01 crore in FY25. It showed an increase of 9.59% on a yearly basis.
  • Operating Profit: INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹246.02 crore in FY26 vs ₹216.32 crore in FY25. It showed an increase of 13.73% on a year-on-year basis.
  • Net Profit: INDRAPRASTHA MEDICAL CORP reported a net profit of ₹183.62 crore in FY26 vs ₹160.99 crore in FY25. It showed an increase of 14.06% on a yearly basis.

INDRAPRASTHA MEDICAL CORP Quarterly Result Highlights

  • INDRAPRASTHA MEDICAL CORP reported revenue of ₹414.57 crore in Jun 2026, compared with ₹372.14 crore in Mar 2026, representing an increase of 11.40% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹74.82 crore in Jun 2026, compared with ₹55.01 crore in Mar 2026, representing an increase of 36.01% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported a profit of ₹55.85 crore in Jun 2026, compared with ₹41.70 crore in Mar 2026, reflecting an increase of 33.93% on a QoQ basis.
  • The earnings per share (EPS) of INDRAPRASTHA MEDICAL CORP stood at ₹17.56 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
51.00%
FII
2.77%
Other DII
0.57%
Retail and other
45.65%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.41%
Dec 20252.73%
Mar 20262.44%
Jun 20262.77%
Mkt Cap Cr
3,231.93

P/E
17.19

P/B
4.37

ROE
24.80%

D/E
0.05

ROCE
32.39%

Div. Yield
1.13%

EPS(TTM)
20.03
Turnover
1.54

EV/EBITDA
10.05

Net Margin
0.00%

Op. Margin
0.00%

ROA
18.96%

Quick Ratio
0.00

Curr. Ratio
2.51
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Indrapr.Medical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Indrapr.Medical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,25,308.0057.6913.2220.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare96,743.7066.409.0013.42%0.0912.97%91.840.20%0.277.37
MANIPAL HEALTH ENTERPRI L93,280.00102.925.6810.59%0.469.51%0.000.00%0.000.00
Fortis Healthcare68,991.9064.456.9710.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare66,430.20189.1614.978.48%0.3110.10%53.530.23%0.435.20
Narayana Hrudayalaya39,297.6047.078.4717.76%0.7611.42%127.100.23%0.7624.77
Global Health38,865.4069.089.6314.05%0.0615.26%149.240.03%0.7318.46
Dr. Lal Path Labs32,118.7058.7912.8020.13%0.0825.56%147.341.07%0.9130.45
KRISHNA INST OF MED SCI L31,643.30165.758.6010.74%0.637.99%93.540.00%0.426.52
Poly Medicure18,086.4057.805.8210.37%0.0812.71%301.170.20%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INDRAPRASTHA MEDICAL CORP Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,356.36₹1,244.70₹1,098.67₹888.16
Other Income₹22.65₹16.89₹10.03₹3.12
Total Revenue₹1,379.01₹1,261.59₹1,108.70₹891.28
Total Expenses₹1,162.69₹1,095.48₹991.52₹812.21
Profit Before Tax₹216.32₹166.11₹117.18₹79.07
Tax₹55.33₹42.15₹31.03₹20.45
Profit After Tax₹160.99₹123.96₹86.15₹58.62
EPS - Basic₹17.56₹13.52₹9.40₹6.39
EPS - Diluted₹17.56₹13.52₹9.40₹6.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹216.32₹166.11₹117.18₹79.07
Income before WC changes₹241.54₹191.53₹147.75₹117.27
Change in Assets-₹18.82₹14.79-₹21.95₹24.70
Change in Liabilities-₹4.98₹40.67₹28.61-₹28.15
Change in WC-₹23.80₹55.46₹6.66-₹3.45
Cash flow from Operations₹156.75₹200.15₹144.47₹94.30
Cash flow from Investing-₹110.99-₹158.43-₹107.91-₹74.11
Cash flow from Financing-₹45.88-₹32.38-₹26.04-₹3.37
Total Cash Flow-₹0.12₹9.34₹10.52₹16.82
Cash (Start of the year)₹61.60₹52.26₹41.74₹24.92
Cash (End of the year)₹61.48₹61.60₹52.26₹41.74

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹420.49₹415.26₹332.06₹304.28
Current Assets₹431.13₹307.98₹223.08₹157.43
Total Assets₹851.62₹723.24₹555.14₹461.71
Current Liabilities₹178.71₹165.42₹129.63₹93.50
Net Current Asset₹252.42₹142.56₹93.45₹63.93
Non-Current Liabilities₹76.23₹80.06₹46.06₹42.77
Equity Capital₹596.68₹477.76₹379.45₹325.44
Total Equity & Liabilities₹851.62₹723.24₹555.14₹461.71
* All values are in INR Crore
Qty
Bid
60
356.35
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 60
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
40.29
Neutral

ATR (14)
7.55
Neutral

STOCH(9,6)
30.05
Neutral

STOCH RSI (14)
34.94
Neutral

ADX(9)
19.85
Bullish

UO(9)
37.84
Neutral

ROC(12)
-2.94
Bearish

WillR(14)
-72.24
Neutral
Period
Simple value
Exponential vaue

5D
359.87
359.59

10D
365.25
363.5

20D
371.02
367.24

50D
372.98
373.09

100D
383.46
382.08
Volume trend — traded volume by day
3 Sep1L
2 Sep2L
1 Sep2L
31 Aug1L
28 Aug1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
INDRAPRASTHA MEDICAL CORP Share Price
INDRAPRASTHA MEDICAL CORP
Healthcare Services
Add Stock
Add Another

INDRAPRASTHA MEDICAL CORP Share Price FAQs











INDRAPRASTHA MEDICAL CORP share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837